FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068432045> ?p ?o ?g. }

• W2068432045 endingPage "876" @default.
• W2068432045 startingPage "867" @default.
• W2068432045 abstract "Background We tested whether pre-HAART viraemia affects the achievement and maintenance of virological success in HIV-1-infected patients starting modern first-line therapies. Methods A total of 1,430 patients starting their first HAART (genotype-tailored) in 2008 (median; IQR: 2006–2009) were grouped according to levels of pre-HAART viraemia (≤30,000, 30,001–100,000, 100,001–300,000, 300,001–500,000 and >500,000 copies/ml). The impact of pre-therapy viraemia on the time to virological success (viraemia ≤50 copies/ml) and on the time to virological rebound (first of two consecutive viraemia values >50 copies/ml after virological success) were evaluated by Kaplan–Meier curves and Cox regression analyses. Results Median pre-HAART viraemia was 5.1 log 10 copies/ml (IQR 4.5–5.5), and 53% of patients had viraemia >100,000 copies/ml. By week 48, the prevalence of patients reaching virological success was >90% in all pre-HAART viraemia ranges, with the only exception of range >500,000 copies/ml (virological success =83%; P<0.001). Higher pre-HAART viraemia was tightly correlated with longer median time to achieve virological success. Cox multivariable estimates confirmed this result: patients with pre-HAART viraemia >500,000 copies/ml showed the lowest hazard of virological undetectability after adjusting for age, gender, pre-HAART CD4 + T-cell count, transmitted drug resistance, calendar year and third drug administered (adjusted hazard ratio [95% CI]: 0.27 [0.21, 0.35]; P<0.001). Pre-HAART viraemia >500,000 copies/ml was also associated with higher probability of virological rebound compared with patients belonging to lower viraemia strata at weeks 4, 12 and 24 ( P=0.050). Conclusions At the time of modern HAART, and even though an average >90% of virological success, high pre-HAART viraemia remains an independent factor associated with delayed and decreased virological success. Patients starting HAART with >500,000 copies/ml represent a significant population that may deserve special attention." @default.
• W2068432045 created "2016-06-24" @default.
• W2068432045 creator A5002994994 @default.
• W2068432045 creator A5003231872 @default.
• W2068432045 creator A5005284577 @default.
• W2068432045 creator A5017759465 @default.
• W2068432045 creator A5021206943 @default.
• W2068432045 creator A5025683557 @default.
• W2068432045 creator A5032359240 @default.
• W2068432045 creator A5034619862 @default.
• W2068432045 creator A5036465251 @default.
• W2068432045 creator A5039193151 @default.
• W2068432045 creator A5047826305 @default.
• W2068432045 creator A5049398766 @default.
• W2068432045 creator A5052591896 @default.
• W2068432045 creator A5059408290 @default.
• W2068432045 creator A5061040356 @default.
• W2068432045 creator A5061140872 @default.
• W2068432045 creator A5064623739 @default.
• W2068432045 creator A5066246677 @default.
• W2068432045 creator A5066479212 @default.
• W2068432045 creator A5069515493 @default.
• W2068432045 creator A5069733218 @default.
• W2068432045 creator A5075357953 @default.
• W2068432045 creator A5080590367 @default.
• W2068432045 creator A5082122622 @default.
• W2068432045 creator A5082925576 @default.
• W2068432045 creator A5086677515 @default.
• W2068432045 creator A5091281560 @default.
• W2068432045 creator A5091343930 @default.
• W2068432045 creator A5091721224 @default.
• W2068432045 date "2013-10-01" @default.
• W2068432045 modified "2023-09-26" @default.
• W2068432045 title "Impact of Pre-Therapy Viral Load on Virological Response to Modern First-Line Haart" @default.
• W2068432045 cites W1570999275 @default.
• W2068432045 cites W1767940945 @default.
• W2068432045 cites W1964622370 @default.
• W2068432045 cites W1965602853 @default.
• W2068432045 cites W1971758213 @default.
• W2068432045 cites W2009473445 @default.
• W2068432045 cites W2012139740 @default.
• W2068432045 cites W2013129339 @default.
• W2068432045 cites W2015796602 @default.
• W2068432045 cites W2017925683 @default.
• W2068432045 cites W2025351576 @default.
• W2068432045 cites W2025910751 @default.
• W2068432045 cites W2034989505 @default.
• W2068432045 cites W2057211130 @default.
• W2068432045 cites W2057784452 @default.
• W2068432045 cites W2057826571 @default.
• W2068432045 cites W2071226541 @default.
• W2068432045 cites W2078978810 @default.
• W2068432045 cites W2088221871 @default.
• W2068432045 cites W2089151634 @default.
• W2068432045 cites W2097971319 @default.
• W2068432045 cites W2100163253 @default.
• W2068432045 cites W2109046728 @default.
• W2068432045 cites W2115919618 @default.
• W2068432045 cites W2119433625 @default.
• W2068432045 cites W2132486336 @default.
• W2068432045 cites W2150357065 @default.
• W2068432045 cites W2160230582 @default.
• W2068432045 cites W2161206698 @default.
• W2068432045 cites W2161993838 @default.
• W2068432045 cites W2164169368 @default.
• W2068432045 cites W2175055957 @default.
• W2068432045 cites W2318289184 @default.
• W2068432045 cites W2332730811 @default.
• W2068432045 cites W4238205945 @default.
• W2068432045 cites W95077935 @default.
• W2068432045 doi "https://doi.org/10.3851/imp2531" @default.
• W2068432045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23343501" @default.
• W2068432045 hasPublicationYear "2013" @default.
• W2068432045 type Work @default.
• W2068432045 sameAs 2068432045 @default.
• W2068432045 citedByCount "35" @default.
• W2068432045 countsByYear W20684320452013 @default.
• W2068432045 countsByYear W20684320452014 @default.
• W2068432045 countsByYear W20684320452015 @default.
• W2068432045 countsByYear W20684320452016 @default.
• W2068432045 countsByYear W20684320452017 @default.
• W2068432045 countsByYear W20684320452018 @default.
• W2068432045 countsByYear W20684320452019 @default.
• W2068432045 countsByYear W20684320452020 @default.
• W2068432045 countsByYear W20684320452021 @default.
• W2068432045 countsByYear W20684320452022 @default.
• W2068432045 crossrefType "journal-article" @default.
• W2068432045 hasAuthorship W2068432045A5002994994 @default.
• W2068432045 hasAuthorship W2068432045A5003231872 @default.
• W2068432045 hasAuthorship W2068432045A5005284577 @default.
• W2068432045 hasAuthorship W2068432045A5017759465 @default.
• W2068432045 hasAuthorship W2068432045A5021206943 @default.
• W2068432045 hasAuthorship W2068432045A5025683557 @default.
• W2068432045 hasAuthorship W2068432045A5032359240 @default.
• W2068432045 hasAuthorship W2068432045A5034619862 @default.
• W2068432045 hasAuthorship W2068432045A5036465251 @default.
• W2068432045 hasAuthorship W2068432045A5039193151 @default.
• W2068432045 hasAuthorship W2068432045A5047826305 @default.

• next